Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies

• المؤلفون الرئيسيون: Xiaoqiang Liu (مؤلف), Juliana Park (مؤلف), Shengli Xia (مؤلف), Bin Liang (مؤلف), Shuangmin Yang (مؤلف), Yanxia Wang (مؤلف), Olga Syrkina (مؤلف), Nathalie Lavis (مؤلف), Shuzhen Liu (مؤلف), Chenyan Zhao (مؤلف), Jian Ding (مؤلف), Jieqiong Hu (مؤلف), Sandrine I. Samson (مؤلف), Iris A. de Bruijn (مؤلف), for the FSQ01 and FSQ02 Study Groups (مؤلف)
• التنسيق: كتاب
• منشور في: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

A quadrivalent, split-virion influenza vaccine (Shz QIV), containing two influenza A strains, and both B lineages strains, has been developed in China. We report the safety and immunogenicity of Shz QIV in two studies: a single-center, phase I, open-label, safety trial (n = 101) and a multicenter, p...